Temple Health has been awarded a $700,000 three‑year grant from the William Penn Foundation to develop the Temple Family Thriving Program, a trauma‑informed initiative that integrates caregiver and early childhood support directly into prenatal and postpartum care.

Dr. Jimmy Holder, associate professor in pediatrics at Baylor College of Medicine and Principal investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, and his team have received a grant for up to $17.25 million from Aligning Research to Impact Autism (ARIA) to become a part of the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network.

A new study finds that employer points systems, which penalize workers for absences regardless of the reason, are strongly associated with presenteeism, the practice of showing up to work while sick, and that these systems undermine the public health benefits of paid sick leave laws even in jurisdictions where such protections are on the books.

New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.

Boston Children's Hospital has been awarded up to $17.25 million to serve as a participating site within the Innovative Medicine and Precision Approaches to Clinical Trials (IMPACT) Network, an international effort funded through Aligning Research to Impact Autism (ARIA). This investment is part of a major, short-term natural history and clinical endpoint study aimed at speeding up the development of urgently needed treatments for children with profound autism and related neurodevelopmental disabilities (NDDs), with or without genetic causes.

About The Study: During a press conference on September 22, 2025, President Trump and top health officials endorsed use of leucovorin, a generic drug formulated from folinic acid, for treatment of autism, and urged against acetaminophen use during pregnancy, stating concerns about its risk for development of autism in children. The White House announcement was associated with large increases in internet searches over the subsequent 2 weeks, including more than 1 million additional searches for leucovorin; nearly 81,000 additional purchasing interest searches for leucovorin, folinic acid, or folate; and more than 4 million additional searches for acetaminophen with pregnancy or autism.